These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 25523882)
21. [Current views on the metabolic syndrome and the effects of antipsychotic drugs]. Fodor M Psychiatr Hung; 2011; 26(3):196-200. PubMed ID: 21799222 [TBL] [Abstract][Full Text] [Related]
22. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716 [TBL] [Abstract][Full Text] [Related]
23. Management of atypical antipsychotic drug-induced weight gain: focus on metformin. Miller LJ Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423 [TBL] [Abstract][Full Text] [Related]
24. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Nasrallah HA Mol Psychiatry; 2008 Jan; 13(1):27-35. PubMed ID: 17848919 [TBL] [Abstract][Full Text] [Related]
25. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. Maayan L; Correll CU J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172 [TBL] [Abstract][Full Text] [Related]
26. Endocrine functions of adipose tissue. Waki H; Tontonoz P Annu Rev Pathol; 2007; 2():31-56. PubMed ID: 18039092 [TBL] [Abstract][Full Text] [Related]
27. A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia. Atti AR; Ferrari Gozzi B; Zuliani G; Bernabei V; Scudellari P; Berardi D; De Ronchi D; Tarricone I; Menchetti M Int Psychogeriatr; 2014 Jan; 26(1):19-37. PubMed ID: 24103643 [TBL] [Abstract][Full Text] [Related]
28. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies. Bou Khalil R Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510 [TBL] [Abstract][Full Text] [Related]
29. Atypical antipsychotics and diabetes mellitus. Lichiardopol R Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621 [TBL] [Abstract][Full Text] [Related]
30. Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms. Reynolds GP; Kirk SL Pharmacol Ther; 2010 Jan; 125(1):169-79. PubMed ID: 19931306 [TBL] [Abstract][Full Text] [Related]
35. Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children. Devlin AM; Panagiotopoulos C Pharmacogenomics; 2015; 16(9):981-96. PubMed ID: 26107755 [TBL] [Abstract][Full Text] [Related]
36. Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies. Burghardt KJ; Seyoum B; Mallisho A; Burghardt PR; Kowluru RA; Yi Z Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():55-63. PubMed ID: 29325867 [TBL] [Abstract][Full Text] [Related]
37. Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians. Hasnain M; Vieweg WV; Hollett B Postgrad Med; 2012 Jul; 124(4):154-67. PubMed ID: 22913904 [TBL] [Abstract][Full Text] [Related]
38. Association Between Antipsychotic Medication Use and Diabetes. Holt RIG Curr Diab Rep; 2019 Sep; 19(10):96. PubMed ID: 31478094 [TBL] [Abstract][Full Text] [Related]